Dr. Hahm has more than 25 years of experience in biomedical research and commercial development. He obtained Ph.D. degree in biomedical science at the University of South Carolina. He worked as a visiting/staff fellow at the National Institute of Mental Health and as a research faculty at Johns Hopkins University. Dr. Hahm has been involved in establishing two other start-up biotech companies as a founding member during the past ten years.

Mr. Oltac Unsal’s financial career spans structured finance and principal investments at Credit Suisse First Boston, Goldman Sachs, and Smyrna Capital. As a successful co-founder and/or the first executive business employee of four Silicon Valley startups, he brings a deep entrepreneurial know-how to RAFAGEN. He holds an MBA from Stanford Business School and a BA in Philosophy, Economics and Politics from Whitman College.